Introducing the Mitochondria Innovation Initiative (MITO2i) and Toronto Dementia Research Alliance (TDRA)

Fellowship Competition 2021

DEADLINE FOR SUBMISSION:
THURSDAY SEPTEMBER 30TH, 2021 AT 5PM EST

The Mitochondria Innovation Initiative (MITO2i) and the Toronto Dementia Research Alliance (TDRA) have partnered to co-fund an innovative new fellowship to support research that explores the role of the mitochondria in dementia.  Fellows will be engaged in collaborative, multi-disciplinary research that aligns with the goals of MITO2i and the TDRA, to understand the role of mitochondria in complex brain diseases and to advance the path to a cure for dementia, respectively.

This MITO2i/TDRA fellowship is open to MD specialists or PhDs pursuing post-doctoral fellowships.  Candidates with an MD must have completed a residency training program in geriatric medicine, neurology, neurosurgery, physical medicine and rehabilitation, psychiatry, or other brain-related specialty.  If the successful candidate is an MD, it is expected that at least 60% of the fellow’s time will be devoted to research.

Fellows will lead a research project that focuses on mitochondrial function or dysfunction in relation to dementia.  Key areas of focus include biomarkers of mitochondrial dysfunction, and the impact of these disorders on cognitive and functional abilities, quality of life, interpersonal relationships, and other biological correlates.

Funding:

The successful applicant will receive $60,000K towards salary compensation for one year starting January 2022.

Eligibility Requirements

 

Applicants must:

  • Have completed a residency training program in geriatric medicine, neurology, neurosurgery, physical medicine and rehabilitation, psychiatry, or other brain-related specialty OR,

  • Hold a PhD and be in the first or second year of a post-doctoral fellowship

  • Candidates must be under the Supervision of a PI at one of the following sites: Baycrest, Centre for Addiction and Mental Health (CAMH), Ontario Shores Centre for Mental Health Sciences, St. Michael’s Hospital, Sunnybrook Health Sciences Centre, University Health Network/Toronto Western Hospital/Toronto Rehabilitation Institute

 

Selection Process:

The Selection Panel is led by the Directors of the Mitochondrial Innovation Initiative (MITO2i) (Dr. Ana Andreazza) and the Toronto Dementia Research Alliance (TDRA) (Dr. Tarek Rajji), along with a panel of committee members.

Application Process and Timelines:

The MITO2i/TDRA Fellowship will launch in August 2021.  Applications will be due September 30th 2021. 

Interested applicants should send:

  • An updated CV; 

  • A one-page statement indicating their interest in mitochondria and dementia,

  • A one-page research proposal that is co-signed by the Fellow's Supervisor, and 

  • Please also provide the names and contact information for three referees.

 

Please send your application to: info@mito2i.ca by September 30th at 5:00pm EST.

After an initial review, you may be invited to a virtual interview.

Interviews will take place in October and the successful applicant will be notified in November for funding to flow in January 2022.

***Only one fellowship selected and approved by the Selection Panel will be awarded the funding this year.

 

 

For more information:

The MITO2i contact is the Associate Director, Strategy & Partnerships, Sonya Brijbassi s.brijbassi@utoronto.ca.  The TDRA contact will be the Director, Strategy & Operations, Luca Pisterzi, Luca.Pisterzi@camh.ca.

About the Organizations

MITO2i is an institutional Strategic initiative of U of T hosted by the Temerty Faculty of Medicine.  The mission of MITO2i is to transform our understanding of the role of mitochondria in human health and disease.  MITO2i brings together a network of researchers, clinicians, patients and advocates, academic institutions, NGOs and industry partners.  Together with its partners, MITO2i aims to deliver supporting technologies, integrative platforms, and interdisciplinary knowledge that will lead to a paradigm shift in the way clinicians approach the diagnosis and treatment of disease and consider the potential role of mitochondrial dysfunction in multiple and prevalent medical conditions.

Established in 2012, the TDRA is a collaboration among the University of Toronto, Baycrest, Centre for Addiction and Mental Health (CAMH), Ontario Shores Centre for Mental Health Sciences, Sunnybrook Health Sciences Centre, and the University Health Network. TDRA is working together to better understand, prevent and treat dementia by creating a stronger link between basic science and clinical research, embedding research into care, improving outreach and education to the community, and increasing the efficiency of collaborative research processes across the city.

DEADLINE FOR SUBMISSION: 

THURSDAY SEPTEMBER 30th, 2021 at 5pm EST

 

All submissions should be sent to info@mito2i.ca

For further questions, please contact:

Sonya Brijbassi

Associate Director, Strategy & Partnerships

Sonya.brijbassi@mito2i.ca